Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

作者：Barbara R. Haight, Susan M. Learned, Céline M. Laffont, Paul J. Fudala, Yue Zhao, Amanda Garofalo, Mark K. Greenwald, Vijay R. Nadipelli, Walter Ling, Christian Heidbreder, James Andersen, Genie L. Bailey, Scott Robert Bartley, Michael J. Biunno, Brent Boyett, Jesse M. Carr, Eduardo Cifuentes, Sandra Daniela Duarte-Sckell, Otto R. Dueno, Boyde Harrison, David Hassman, Kent Hoffman, Valentin Isacesu, Saleem Ishaque, Rishi Kakar, Kyle M. Kampman, Richard D. Knapp, George Konis, Jelena Kunovac, Joseph A. Kwentus, Lawrence S. Levinson, Shishuka Malhotra, Vishaal Mehra, Ricky Mofsen, Marvin L. Peyton, Gita G. Pujari, Rakesh Ranjan, Daniel Rutrick, Gregory Seal, Scott Daniel Segal, Rajinder Shiwach, Haydn M. Thomas, Peter Paul Ventre, Amit K. Vijapura, David P. Walling, Katharina Wiest · 发表于：The Lancet · 年份：2019 · DOI：10.1016/s0140-6736(18)32259-1 · 被引用次数：287 · 研究领域：Opioid Use Disorder Treatment、HIV, Drug Use, Sexual Risk、Substance Abuse Treatment and Outcomes